Should preoperative, post-chemoradiotherapy endoscopy be routine for esophageal cancer patients?

Diseases of the Esophagus

Volumn 17, Issue 2, 2004, Pages 129-135

  Shaukat, A ^a   Mortazavi, A ^a   Demmy, T ^b   Nava, H ^b   Wilkinson, N ^b   Yang, G ^b   Kepner, J ^b   Javle, Milind ^a,b  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Endoscopy; Esophageal cancer; Esophagoscopy; Neoadjuvant; Preoperative

Indexed keywords

CISPLATIN; FLUOROURACIL; OXALIPLATIN;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENDOSCOPIC BIOPSY; ESOPHAGITIS; ESOPHAGOSCOPY; ESOPHAGUS CANCER; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HUMAN; HUMAN TISSUE; MALE; MINIMAL RESIDUAL DISEASE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; TUMOR VOLUME;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGOSCOPY; ESOPHAGUS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES;

EID: 4043150038     PISSN: 11208694     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2004.00389.x     Document Type: Article

References (38)

1. Coia L, Minsky B, Berkey B et al. Outcome of patients receiving radiation for cancer of the esophagus: Results of the 1992-94 patterns of care study. J Clin Oncol 2000; 18: 455-62.
2. Herskovic A, Leichman L, Lattin P et al. Chemoradiation with and without surgery in the thoracic esophagus: the Wayne State experience. Int J Radiat Oncol Biol Phys 1988; 15: 655-62.
3. Coia L R, Paul A R, Engstrom P F. Combined radiation and chemotherapy as primary management of adenocarcinoma of the esophagus and gastroesophageal junction. Cancer 1988; 61: 643-9.
4. Gill P G, Jamieson G G, Denham J et al. Treatment of adenocarcinoma of the cardia with synchronous chemotherapy and radiotherapy. Br J Surg 1990; 77: 1020-3.
5. Wolfe W G, Vaughn A L, Seigler H F, Hathorn J W, Leopold K A, Duhaylongsod F G. Survival of patients with carcinoma of the esophagus treated with combined-modality therapy. J Thorac Cardiovasc Surg 1993; 105: 749-55.
6. Coia L R, Engstrom P F, Paul A R, Stafford P M, Hank G E. Long-term results of infusional 5-FU, mitomycin-C, and radiation as primary management of esophageal carcinoma. Int J Radiat Oncol Biol Phys 1991; 20: 29-36.
7. Walsh T N, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy T P J. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996; 335: 462-7.
8. Bosset J F, Gignoux, M, Triboulet J P et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous cell cancer of the esophagus. N Engl J Med 1997; 337: 161-7.
9. Forastiere A A, Orringer M B, Perez-Tamayo C, Urba S G, Zahurak M, Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: final report. J Clin Oncol 1993; 11: 1118-23.
10. Schlag P M. Randomized trial of preoperative chemotherapy for squamous cell cancer of the esophagus. Arch Surg 1992; 127: 1446-50.
11. Stewart J R, Hoff S J, Johnson D H et al. Improved survival with neoadjuvant therapy and resection for adenocarcinoma of the esophagus. Ann Surg 1993; 218: 571-6.
12. Adelstein D J, Rice T W, Tefft M et al. Aggressive concurrent chemoradiotherapy and surgical resection for proximal esophageal squamous cell carcinoma. Cancer 1994; 74: 1680-5.
13. Leichman L, Steiger Z, Seydel H G et al. Preoperative chemotherapy and radiation therapy for patients with cancer of the esophagus: a potentially curative approach. J Clin Oncol 1984; 2: 75-9.
14. Cooper J S, Guo M D, Herskovic A, et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Ther Oncol Group JAMA 1999; 281: 1623-7.
15. Kelsen D P, Ginsberg R, Pajak T F, Sheahan D G, Gunderson L et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 1998; 339: 1979-84.
16. Scoitiniotis I, Kochman M, Lewis J, Furth E, Rosato E, Ginsberg G. Accuracy of EUS in the evaluation of Barrett's esophagus and high grade dysplasia or intramucosal carcinoma. Gastrointest Endosc 2001; 54: 689-96.
17. Adelstein D J, Rice T W, Boyce G A et al. Adenocarcinoma of the esophagus and the gastroesophageal junction: clinical and pathologic assessment of response to induction chemotherapy. Am J Clin Oncol 1994; 17: 14-18.
18. Bates B A, Detterbeck F C, Bernard S A, Qaqish B F, Tepper J E. Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma. J Clin Oncol 1996; 14: 156-63.
19. Hermanek P, Sobin L H, (eds). UICC TNM Classification of Malignant Tumours, 4th edn. Berlin: Springer-Verlag 1987.
20. Chen J. Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit. Psychol Bull 1968; 70: 213-20.
21. Therasse P, Arbuck S G, Eisenhauer E A, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000; 92: 205-16.
22. Terz J J, Leong L A, Lipsett J A, Wagman L D. Preoperative chemotherapy and radiotherapy for cancer of the esophagus. Surgery 1993; 114: 71-5.
23. Cameron A J, Carpenter H A. Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study. Am J Gastroenterol 1997; 92, 586-91.
24. Reid B J, Blount P L, Feng Z, Levine D S. Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia. Am J Gastroenterol 2000; 95: 3089-96.
25. Levine D S, Haggitt R C, Blount P L, Rabinovitch P S, Rusch V W, Reid B J. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology 1993; 105: 40-50.
26. Rusch V W, Levine D S, Haggitt R, Reid B J. The management of high-grade dysplasia and early cancer in Barrett's esophagus. A multidisciplinary problem. Cancer 1994; 74: 1225-9.
27. Dittler H J, Pesarini A C, Siewert J R. Endoscopic classification of esophageal cancer: correlation with the T stage. Gastrointest Endosc 1992; 38: 662-8.
28. Japanese Society for Esophageal Disease, (eds). Guidelines for the Clinical and Pathologic Studies on Carcinoma of the Esophagus, 8th edn. Tokyo: Kanebara, 1992.
29. Tahara M, Ohtsu A, Hironaka S et al. Criteria of complete response (CR) for primary site in the treatment for esophageal cancer. Abstract no. 638, American Society of Clinical Oncology 2001. Available at http://www.asco.org/ac/1,1003,_12002636-00_18-0010-00_19-00638,00.asp.
30. Bowrey D J, Clark G W, Roberts S A et al. Serial endoscopic ultrasound in the assessment of response to chemoradiotherapy for carcinoma of the esophagus. J Gastrointest Surg 1999; 3: 462-7.
31. Chak A, Canto M I, Cooper G S et al. Endosonographic assessment of multimodality therapy predicts survival on esophageal carcinoma patients. Cancer 2000; 88: 1788-95.
32. Laterza E, de Manzoni G, Guglielmi A, Rodella L, Tedesco P, Cordiano C. Endoscopic ultrasonography in the staging of esophageal carcinoma after preoperative radiotherapy and chemotherapy. Ann Thorac Surg 1999; 67: 1466-9.
33. Isenberg G, Chak A, Canto M et al. Endoscopic ultrasound (EUS) in restaging of esophageal cancer after adjuvant chemoradiation. Gastrointest Endosc 1998; 48: 158-63.
34. Zuccaro G, Rice T W, Goldblum. J et al. Endoscopic ultrasound cannot determine suitability for esophagectomy after aggressive chemoradiotherapy for esophageal cancer. Am J Gastroenterol 1999; 94: 906-12.
35. Kato H, Kuwano H, Nakajima M, et al. Usefulness of positron emission tomography for assessing the response of neoadjuvant chemoradiotherapy in patients with esophageal cancer. Am J Surg 2002; 184: 279-83.
36. Flamen P, Van Cutsem E, Lerut A, el al. Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer. Ann Oncol 2002, 13: 361-8.
37. Brucher B L, Weber W, Bauer M et al. Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography. Ann Surg 2001; 233: 300-9.
38. Weber W, Ott K, Becker K et al. Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging. J Clin Oncol 2001; 19: 3058-65.